Only 5 per cent of people infected with hepatitis B virus receive treatment
While 94 million people out of 292 million hepatitis B patients in 2016 were eligible for antiviral treatment, just 4.8 million got it, says a study
वैज्ञानिकों ने बनाया नकली दवाओं से बचाने वाला सुरक्षा टैग
भारत में बिकने वाली करीब 25 फीसदी दवाएं नकली होती हैं, ऐसे में लाखों लोगों का जीवन बचाने में यह टैग बड़ी अहम भूमिका ...
US sound and fury over drug prices
The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?
India, the antibiotic capital of the world
Antibiotics are often used to treat diarrhoea and upper respiratory tract infections, which can be reduced by improving sanitation and personal …
RCEP deal to make investors stronger, people weaker, says trade group
The deal will affect access to medicines and seeds by raising the standards of intellectual property rights, claims Forum of Trade Justice
Patients pay for high margins of pharma firms
Patients in India end up paying more for medicines and all kinds of treatment as prevailing conditions do not allow the market to function …
Online drug sale ban: Is there a need to regulate e-pharmacies?
Following an interim ban on online sale of medicines, many questions have been raised on the need for checks and balances
Indian pharma firms receive 34% of FDA warnings this year
These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices
Beware of Japan's trade ambitions
Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines
Drug pricing policies bent to favour pharma industry, allege health experts
Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports